Aims
Introduction
Ischaemic mitral regurgitation (IMR) is a type of functional regurgitation that arises as a consequence of left ventricular (LV) remodelling after myocardial infarction. The basis for IMR is tethering of the mitral valve by apical and posterior migration of the papillary muscles that leads to an increasing tenting area, restriction to systolic closure, and poor coaptation. 1 Ischaemic mitral regurgitation significantly affects the prognosis of patients, doubling mortality and increasing the risk of heart failure. [2] [3] [4] In chronic inferior myocardial infarction (CII), asymmetric remodelling of the left ventricle causes asymmetric tenting, 5 Recent studies have shown that the mitral valve is not an inert structure; it has a dynamic cellular microenvironment capable of actively adapting to stress imposed by the ventricular cavity. Indeed, the mitral valve may enlarge to compensate for LV remodelling and tenting, improving its coaptation area and thus preventing or decreasing the severity of mitral regurgitation. This enlarging process is termed 'plasticity'. Studies have shown that mechanical tethering is a trigger for mitral plasticity, [6] [7] [8] [9] and it is purported that this increase in leaflet length represents an adaptation mechanism. However, not all CII patients exhibit plasticity, and in some that do, it may be insufficient to prevent haemodynamically significant mitral regurgitation. Our primary objective was to identify clinical factors associated to the presence or absence of mitral plasticity in patients with CII. Secondary objectives were to determine if mitral plasticity correlates with the severity of mitral regurgitation and identify structural LV characteristics beyond the mitral valve that could be associated to plasticity.
Methods Patients
We conducted a retrospective, observational, and cross-sectional study.
From January 2015 to January 2016, consecutive patients with CII (with or without IMR) were identified clinically and by echocardiography. We defined CII if it had occurred > _6 months before inclusion in the study; all of them had only single-vessel right coronary artery disease and had received revascularization procedure in the weeks following the infarction. Patients with other infarcted areas, significant coronary lesions in other vascular territories or with other valvulopathies different to IMR were not eligible to participate. In addition, we excluded patients with poor acoustic windows and those who did not have the required echocardiographic views for the study (Figure 1) . A control group was assembled with all consecutive healthy participants included in our institution's Mexican population evaluation of LV size and function, which had normal echocardiograms and no prior coronary history or chronic diseases. Only those control echocardiograms that had the necessary mitral plasticity views and measurements were chosen. All participants had a complete medical history, 12-lead resting electrocardiogram, and transthoracic echocardiography (TTE). This study follows the Helsinki guidelines and was approved by the institution.
Echocardiographic study
Conventional transthoracic echocardiograms were performed using a Philips iE33 ultrasound system (Philips Healthcare, Andover, MA, USA), and GE vívid 9 XD Clear, following current guidelines, 10 and all patients had normal systemic blood pressure at the time of the study.
Mitral plasticity definition
Plasticity was defined as an increase in the length of the anterior and/or posterior mitral leaflets and first order posterior tendinous chords. We measured these three structures in a linear manner: the anterior leaflet (segment A2), the posterior leaflet (segment P2), and a first order (primary) tendinous cord of the posterior leaflet. The value accepted as normal for valve lengths was derived from anatomopathological studies of normal human hearts, where the length of the leaflets (measured from the annulus to the free edge of each leaflet) is 22-23 mm and 12-13 mm, for the anterior and posterior leaflets, respectively; normal length of tendinous cords is 18-22 mm. 11, 12 Therefore, we considered increased leaflet length a measurement of > _24 mm for the anterior leaflet, > _14 mm for the posterior leaflet and >24 mm for the chords. In our study, we considered that patients had mitral plasticity when two of the three measured structures had length above normal; having two structures with elongation decreases false positives and increases specificity in identification of these patients.
Plasticity evaluation technique and other mitral valve measurements
On the parasternal long axis view, length of the segments A2 and P2 was evaluated at end-diastole, taking care not to contaminate the measurement with the subvalvular apparatus; the image was followed frame by frame so that it would clearly identify the valve and subvalvular apparatus. In the same parasternal long axis and at end-diastole, the anteroposterior diameter of mitral annulus was measured ( Figure 2 ). Subsequently, advancing frame by frame, the maximum anteroposterior diameter of the mitral annulus was pursued during early-systole. Finally, the image was advanced to end-systole in order to measure tenting area, coaptation depth and total length of the first order posterior chord. This last measurement was obtained from an average of threechord measurements, which were taken from the junction of the ventricular free edge of the leaflet to its union with the posteromedial papillary muscle. A final evaluation was performed in an apical modified twochamber view to identify both papillary muscles heads, and the distance between the anatomic mitral annulus and papillary muscles was measured in both systole and diastole. In the evaluation of IMR, this projection are used routinely in our laboratory ( Figure 2) .
Assessment of the severity of mitral regurgitation
Depending on the number of jets observed in multiple windows, we used two main methods: In the case of a single jet, the vena contracta was measured in the axis perpendicular to the regurgitant jet and the flow convergence method was measured parallel to the jet. In the ischaemic context according to the work of Lancellotti, functional IMR has been defined as severe for lower values of regurgitant volume (> _30 mL) and EROA (> _20 mm 2 ). 13 The vena contracta was considered to denote severe IMR if > _4 mm. 14 If two or more jets were found, severity assessment was performed with continuity method by Doppler, according to the recommendations for the assessment of valvular regurgitation. 15 In all cases, indirect haemodynamic information such as left atrial volume, LV diastolic diameter/volume, mitral E velocity, mitral regurgitation continuous-wave Doppler envelope density, were taken into account. The intra-and interobserver variability of the estimated values was calculated using the within-subject coefficient of variation and intraclass correlation coefficient in 20 randomly chosen study patients. The STATA 12.1 statistical program was used.
Statistics analysis

Results
Clinical and echocardiographic findings in the CII group vs. controls A total of 192 patients were eligible during the study period (124 CII patients and 68 controls), of which 55 were eliminated (33 CII and 22 controls) due to poor acoustic windows and/or absence of required echocardiographic views for the study ( Figure 1 ). Therefore, a total of 137 patients were included, of whom 91 had CII and 46 subjects were controls. Demographic characteristics are shown in Table 1 . As compared to controls, CII patients were older [59 (50-69) vs. 25 (21-44) years, P < 0.001] and mostly men (80% vs. 46%, P < 0.001). This group also had a higher prevalence of type 2 diabetes mellitus (DM2), systemic hypertension, dyslipidaemia, and smoking when compared with controls. In addition, the CII group had significantly higher levels of creatinine, blood urea nitrogen, and lower levels of High density lipoprotein cholesterol than the control group. Patients received conventional anti-ischaemic treatment, including statins, therefore, the CII group had less total cholesterol than control group ( Table 1) .
Echocardiographic measurements including LV remodelling and mitral valve plasticity are shown in Table 2 . There were statistically significant differences between groups in the diameter and volume of cavities, systolic ventricular function, ventricular mass, and thickness of the left ventricle, suggesting substantial LV remodelling in the CII group. Mitral regurgitation of any degree was more frequent in CII patients (88% vs. 11%, P < 0.003). Regarding the mitral valve apparatus and mitral plasticity, the CII group had significantly larger mitral antero-posterior annulus diameters with less annular fractional shortening, mitral leaflets and posterior chords were significantly longer, and tenting area and coaptation depth were significantly larger, when compared with controls ( Table 2 ). The distance between the mitral annulus and the posterior papillary muscle was larger in CII patients. Interestingly, the distance between the mitral annulus and the anterior papillary muscle was also larger in the CII group, suggesting concomitant anterior papillary muscle apical displacement in this group, despite single-vessel disease prior inferior infarction in these patients ( Table 2 ).
Echocardiographic findings in CII patients with and without plasticity
Of 91 CII patients, 26 received emergency primary percutaneous coronary intervention (PCI) at the time of infarction (at our centre), 34 received thrombolysis at local facilities and were then referred to our institution for revascularization, and 31 patients presented late after the event and did not receive emergency PCI or thrombolysis, but underwent elective angiography and PCI within the following 2 months (Figure 1) .
Of the 91 patients with CII, 60 exhibited mitral plasticity with significantly larger anterior and posterior mitral leaflet lengths; 26 ± 2.5 mm vs. 20.7 ± 2.5 mm and 16.5 (15-19) mm vs. 13 (12-14.2) mm, respectively, both P < 0.001 (Table 3) . Similarly, posterior chordal length was increased in these patients; 28.8 ± 6.9 mm vs. 22.3 ± 7.9 mm, P < 0.001, when compared with 31 CII patients without plasticity. Importantly, these striking differences in anterior leaflet, posterior leaflet, and posterior chordal length remained highly significant when corrected by patients' heights (all < _0.002, Table 3 ). Importantly, time from infarction to study TTE was not different between plasticity and no-plasticity groups [306 (183-652) days vs. 327 (213-1118) days, respectively, P = 0.37], and there was no association between time-to-study and anterior leaflet, posterior leaflet, and chordal measurements (all P > _ 0.23). Regarding medications, 14/ 31(45%) of patients with no plasticity were on angiotensin converting enzyme-inhibitor and beta-blocker vs. 36/60(60%) of patients with plasticity, P = 0.19. Ninety percent of patients in both groups were on statins. Plasticity parameters were also not different between typeof-treatment groups (primary angioplasty, thrombolysis, and scheduled angioplasty), all P > _ 0.08.
Other structural echocardiographic findings observed in CII patients with mitral plasticity were a greater diastolic anteroposterior length of the mitral annulus (P < 0.043), and a greater distance between the mitral annulus and anterior papillary muscle in systole (P < 0.049). Patients with plasticity had less severe IMR (8% vs. 29%, P < 0.02) and less moderate IMR (20% vs. 39%, P < 0.04), when compared with patients without plasticity ( Table 3) . Interestingly, the most striking differences in length in patients with no or mild IMR vs. > _moderate IMR were seen for the anterior leaflet (25.5 ± 3.3 vs. 22.4 ± 3.1 mm, respectively; P < 0.001) and the chordal length (28.4 ± 7.2 vs. 24.1 ± 8.2 mm, respectively; P < 0.01). The posterior leaflet length difference was not significant (16.1 ± 2.6 vs. 15 ± 3.1, respectively; P = 0.08).
Clinical predictors in CII patients with and without plasticity
Bivariate analysis of clinical factors was performed in the CII group according to the presence or absence of mitral plasticity ( Table 4) . Clinical factors related with no mitral valve plasticity were older age (P < 0.029) and smoking (P < 0.033). Conversely, higher haemoglobin level, greater time-duration of DM2, of systemic hypertension, and of dyslipidaemia were related with mitral plasticity (P < 0.001, P < 0.033, P < 0.039, and P < 0.027, respectively) ( Table 4) .
Multivariate analysis demonstrated that smoking [odds ratio (OR) 0.03, 0.002-0.57; P < 0.019] was an independent factor associated with no plasticity, while greater time-duration of DM2 (OR 1.19, 1.007-1.42; P < 0.04), and higher haemoglobin level (OR 2.17, 1.25-3.76; P < 0.005) were associated with greater plasticity (Table 5) . Importantly, when LV ejection fraction and mitral AP diastolic annular diameter were added to the multivariate analysis, smoking, greater time-duration of DM2 and higher haemoglobin remained significant predictors (P < 0.02, P < 0.02 and P < 0.01, respectively).
Intra-and interobserver variability of echocardiographic parameters of mitral plasticity is shown in Table 6 .
Discussion
Our study examined LV remodelling and mitral plasticity in patients with prior inferior myocardial infarction who had undergone revascularization. Compared with controls, patients with CII incurred significant LV remodelling. However, when comparing CII patients with and without plasticity, LV remodelling in patients who developed mitral plasticity was not significantly different to those patients without plasticity, suggesting that although LV remodelling is known to be involved in plasticity, other factors are also likely involved in the development of plasticity. Therefore, we studied clinical features and found that longer time-duration of diabetes mellitus and higher haemoglobin level were independently associated with mitral plasticity development, while smoking independently associated with no mitral plasticity. In addition, we observed that mitral plasticity results in significantly less moderate and severe IMR in CII patients. Interestingly, despite no other significant coronary disease (other than infarctrelated artery) or regionality other than inferior/posterior, we observed an increased anterior papillary muscle-to-annulus length in CII patients as compared to controls, and also in CII with plasticity, when compared with CII patients without plasticity, suggesting not only that ischaemic LV remodelling extends beyond the infarcted area, but that remodelling in areas other than the infarcted is possibly involved as trigger for mitral plasticity.
Determinants of mitral plasticity
Mitral plasticity is a compensatory mechanism that allows the mitral valve to increase its total area and generate a larger coaptation zone, and therefore, decrease and potentially prevent IMR. In previous studies in patients with myocardial infarction and/or dilated cardiomyopathy, the total valvular area increased in response to chronic valve tethering generated by displacement of the papillary muscles, but also, due to stress generated by turbulent IMR jets on the atrial face of the valve when mitral regurgitation is present. 16 The physiology of plasticity involves the reactivation of embryological pathways and active cellular production, culminating with greater mitral valvular area. 17 Chaput et al. showed that mitral leaflet areas measured by threedimensional echocardiography were 35% larger in ischaemic patients with valvular tethering as compared to controls. 18 However, little is known about factors other than LV remodelling that may be associated with the presence or absence of mitral valve plasticity; for example, paracrine factors may be involved in the loss of this 19 In our study, smoking was independently associated with absence of plasticity, an observation that could be explained by the toxic effect of nicotine on both the ventricular and atrial myocardium, since in current smoker and ex-smoker patients there is accelerated accumulation of collagen, with increased expression of type III collagen mRNA, which leads to fibrosis of the atrial and ventricular endothelium with resulting interstitial fibrosis. 20, 21 The adaptive process of mitral valve (plasticity) involves a mesotelial-mesenchymal transformation, which begins in the atrial endothelium and later in the interstitium of the valve itself, 18 therefore, plasticity requires the presence of healthy endothelium to be able to fulfil this compensatory function. The independent association between time-duration of DM2 and plasticity suggests that endocrine mechanisms could be implicated as has been previously suggested. 19 The mitotic effect of insulin, which is present in many patients with DM2 and insulin resistance, combined with the mechanical forces imposed on the mitral valve by tethering may act together in the genesis of plasticity. Interestingly, transforming growing factor beta (TGF ß) is a trigger of plasticity by mesotelialmesenchyimal reactivation 12, 22 and TGF ß levels are increased in patients with insulin resistance. 23 These observations may be particularly important as we search for therapies that could promote valvular plasticity and thus reduce or prevent IMR. Remarkably, our study suggests that a complex LV 'balancing process' is at play in CII patients exhibiting plasticity. Despite the isolated inferior infarction of our patients, we observed apical displacement of the contralateral-anterior papillary muscle in patients with plasticity. A complex global mechanism of adaptation may occur in CII patients PPM-annulus, distance between mitral annulus to base of posterior papillary muscle; APM-annulus, distance between mitral annulus and anterior papillary muscle.
. . . . . . . . . . . .
with plasticity and minor IMR, in which both papillary muscles and tendinous are involved, possibly leading to a 'balancing' of forces within the mitral apparatus. 11 Whether this balance process is LV or mitral dependent or both, is unknown.
In our study, haemoglobin level was strongly associated to the presence of plasticity. We speculate that this may be an expression of mitral regurgitation-related turbulence and low-grade haemolysis. Previous studies have shown that turbulence, shear stress, and 24 This would result in lower haemoglobin levels in CII patients with no plasticity who exhibit significantly worse IMR severity and thus, more low-grade haemolysis. On the other hand, in a group of non-ischaemic dilated cardiomyopathy, 25 the authors showed that anaemia was associated with increased mitral regurgitation volume; patients with more severe mitral regurgitation had lower level of haemoglobin, and the authors proposed that haemoglobin level could predict moderate or severe functional mitral regurgitation. Although the mechanism that links anaemia with mitral regurgitation and different heart failure severity is no yet fully understood, it is clear that in anaemic patients with coronary artery disease, myocardial ischaemia is an additional factor that may worsen ventricular function and prognosis. 26 
Limitations
Although we show that conventional 2D-TTE studies can be performed to evaluate mitral plasticity using specific views that allow visualization of the subvalvular apparatus, with little intra-and interobserver variability, the ideal way of assessing these complex anatomic relationships should be by 3D echocardiography, which we do not have readily easy access to, and this constitutes a limitation of our study. Our study is retrospective, and has a small patient population, suggesting the need to confirm findings in larger patient populations. In that regard, it is likely that a larger patient number could have resulted in statistically-significant differences in LV remodelling between CII patients with and without plasticity. Additionally, there was no clinical follow up and markers of growth, inflammation or plasma insulin levels were not measured. Our findings only apply to patients with CII who have undergone revascularization, and could be different in non-revascularized populations. Based on our findings, a prospective study of valvular plasticity aimed at confirming these observations in being designed.
Conclusion
Compared with healthy controls, patients with chronic CII (> _6 months after infarction) who have been revascularized incur significant LV remodelling. Although remodelling is a proven stimulus for the development of mitral plasticity, our study shows that post-infarction patients who develop mitral plasticity may not necessarily exhibit worse LV remodelling than patients without plasticity, suggesting that other factors are also likely involved. Indeed, longer time-duration of diabetes mellitus and higher haemoglobin level are independently associated with mitral plasticity, while smoking independently associates with no mitral plasticity. Mitral plasticity results in less moderate and severe IMR in these patients. Increased anterior papillary muscle-to-annulus length in CII patients with plasticity suggests complex LV remodelling mechanisms are involved in plasticity.
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